1. Dalleywater W., Powell H.A., Hubbard R.B., Navaratnam V. Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis. Chect. 2015; 147 (1): 150-156. https://doi.org/10.1378/chest.14-0041.
2. Rivera-Lebron B.N., Forfia P.R., Kreider M. et al. Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis. Chest. 2013; 144 (2): 564-570. https://doi.org/10.1378/chest.12-2298.
3. Akintunde A.A. Right ventricular function in patients with heart failure in a cardiac clinic in Southwest Nigeria. Nigerian Med. J. 2017; 58 (1): 7-12. https://doi.org/10.4103/0300-1652.218411.
4. Ben-Shlomo Y., Spears M., Boustred C. et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J. Am. Coll. Cardiol. 2014; 63 (7): 636-646. https://doi.org/10.1016/j.jacc.2013.09.063.
5. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010; 55 (13): 1318-1327. https://doi.org/10.1016/j.jacc.2009.10.061.
6. Vriz O., Magne J., Jarosh J. et al. Local carotid arterial stiffness is an independent determinant of left ventricular remodeling in never-treated hypertensive patients. Blood Press. 2019; 28 (1): 23-33. https://doi.org/10.1080/08037051.2018.1511369.
7. Al-Naamani N., Chirinos J.A., Zamani P. et al. Association of Systemic Arterial Properties with Right Ventricular Morphology: The Multi-Ethnic Study of Atherosclerosis (MESA) - Right Ventricle Study. J. Am. Heart Assoc. 2016; 5 (12): pii: e004162. https://doi.org/10.1161/JAHA.116.004162.
8. Raghu G., Remy-Jardin M., Myers J.L. et al. Diagnosis of idiopathic pulmonary f ibrosis. An Off icial ATS/ERS/ JRS/ALAT Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 2018; 198 (5): e44-68. https://doi.org/10.1164/rccm.201807-1255ST.
9. Chuchalin A.G., Avdeev S.N., Aisanov Z.R. et al. [Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: Federal Guidelines]. Pul'monologiya. 2016; 26 (4): 399-419. https://doi.org/10.18093/0869-0189-2016-26-4-399-419 (in Russian).
10. Panagiotou M., Church A.C., Johnson M.K., Peacock A.J. Pulmonary vascular and cardiac impairment in interstitial lung disease. Eur. Respir. Rev. 2017; 26 (143): pii: 160053. https://doi.org/10.1183/16000617.0053-2016.
11. Van Bortel L.M., Laurent S., Boutouyrie P. et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J. Hypertens. 2012; 30 (3): 445-448. https://doi.org/10.1097/HJH.0b013e32834fa8b0.
12. Townsend R.R., Wilkinson I.B., Schiffrin E.L. et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. J. Hypertens. 2015; 66 (3): 698-722. https://doi.org/10.1161/HYP.0000000000000033.
13. Rudski L.G., Lai W.W., Afilalo J. et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 2010; 23 (7): 685-713. https://doi.org/10.1016/j.echo.2010.05.010.
14. Lang R.M., Badano L.P., Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2015; 28 (1): 1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003.
15. Galderisi M., Cosyns B., Edvardsen T. et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imag. 2017; 18 (12): 1301-1310. https://doi.org/10.1093/ehjci/jex244.
16. Kolb T.M., Hassoun P.M. Right Ventricular Dysfunction in Chronic Lung Disease. Cardiol. Clin. 2012; 30 (2): 243-256. https://doi.org/10.1016/j.ccl.2012.03.005.
17. Hsia C.C. Cardiopulmonary limitations to exercise in restrictive lung disease. Med. Sci. Sports Exerc. 1999; 31 (1, Suppl.): S28-32. https://doi.org/10.1097/00005768-199901001-00005.
18. Cottin V., Le Pavec J., Prévot G. et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur. Respir. J. 2010; 35 (1): 105-111. https://doi.org/10.1183/09031936.00038709.
19. Broder M., Change E., Papoyan E. et al. Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: analysis of Medicare data. Eur. Respir. J. 2016; 48 (Suppl. 60): PA4919. https://doi.org/10.1183/13993003.congress-2016.PA4919.
20. Petersons C.J., Mangelsdorf B.L., Poljak A. et al. Low dose prednisolone and insulin sensitivity differentially affect arterial stiffness and endothelial function: an open interventional and cross-sectional study. Atherosclerosis. 2017; 258: 34-39. https://doi.org/10.1016/j.atherosclerosis.2017.01.033.
21. Karoli N.A., Dolishnyaya G.R., Rebrov A.P. [Diurnal arterial stiffness in males with different phenotypes of chronic obstructive pulmonary disease and hypertension comorbidity]. Klinicist. 2015; 9 (1): 37-41. https://doi.org/10.17650/1818-8338-2015-1-37-41 (in Russian).
22. Makarova M.A., Avdeev S.N., Chuchalin A.G. [Hypoxemia as a potential risk factor for endothelial dysfunction and arterial stiffness in patients with chronic obstructive pulmonary disease]. Pul'monologiya. 2013; (3): 36-40 (in Russian).